Insulin use NIDDM effects insulin treatment pathophysiology non-insulin-dependent diabetes NIDDM herein Short-term studies variable partial reduction excessive hepatic glucose output decrease insulin resistance enhancement beta-cell function beneficial actions due decrease secondary glucose toxicity direct attack primary abnormality Insulin initial treatment new-onset NIDDM presence ketosis significant diabetes-induced weight loss residual obesity severe hyperglycemic symptoms diet-failure patients prospective studies insulin treatment show equal glycemic outcomes slight advantage key goal insulin therapy fasting plasma glucose level contrast conventional use morning injections intermediate- long-acting insulin preliminary studies potential advantages bedtime Obese patients several units insulin daily satisfactory control addition sulfonylurea hyperglycemia insulin dose long-term benefits combination therapy adverse effects insulin treatment NIDDM hypoglycemia elderly gain Self-monitoring blood glucose patients excessive weight gain subtle hypoglycemia Whether insulin causes gain direct effects appetite energy utilization controversial potential adverse effect insulin epidemiological studies associations hyperinsulinemia insulin resistance risk coronary artery disease stroke hypertension potential mechanisms atherogenic action insulin current evidence cause effect insulin therapy dosage 